Eton Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
ETON on Nasdaq
Industry
Pharmaceutical Preparations
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL

Insiders trading volume in the past year

Eton Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Opaleye Management Inc. 10%+ Owner $22.1M +$585K +2.72% Oct 23, 2024
David Krempa Chief Business Officer $4.09M Oct 2, 2024
Norbert Riedel Director Feb 13, 2024
Wilson Troutman CFO and Secretary Feb 7, 2022
Charles J. Casamento Director Feb 13, 2024
Paul V. Maier Director Feb 13, 2024
Jennifer McKie Adams Director Feb 13, 2024
Ipek Erdogan-Trinkaus Chief Commercial Officer Dec 2, 2024
James R. Gruber Chief Financial Officer Feb 13, 2024
Sean Brynjelsen President & CEO, Director Feb 13, 2024

Recent Insider Transactions by Companies or Individuals for Eton Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.